$AQMS
Aqua Metals, Inc.

2023 Q3 Form 10-Q Financial Statement

#000143774923022774 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $25.00K $0.00
YoY Change -100.0%
Cost Of Revenue $1.770M $1.481M
YoY Change 112.48% 41.32%
Gross Profit -$1.745M -$1.481M
YoY Change 109.48% 41.86%
Gross Profit Margin -6980.0%
Selling, General & Admin $3.200M $3.352M
YoY Change 3.19% 15.87%
% of Gross Profit
Research & Development $389.0K $525.0K
YoY Change -20.61% 0.77%
% of Gross Profit
Depreciation & Amortization $254.0K $200.0K
YoY Change 27.0% 100.0%
% of Gross Profit
Operating Expenses $389.0K $525.0K
YoY Change -20.61% 0.77%
Operating Profit -$4.949M -$4.855M
YoY Change 25.8% 22.76%
Interest Expense $87.00K $255.0K
YoY Change 866.67% 2025.0%
% of Operating Profit
Other Income/Expense, Net $402.0K $96.00K
YoY Change 720.41% -87.83%
Pretax Income -$4.547M -$4.759M
YoY Change 17.04% 50.32%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.547M -$4.759M
YoY Change 17.04% 50.32%
Net Earnings / Revenue -18188.0%
Basic Earnings Per Share -$0.04 -$0.06
Diluted Earnings Per Share -$0.04 -$0.06
COMMON SHARES
Basic Shares Outstanding 103.2M 83.14M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.60M $6.196M
YoY Change 175.48% -3.56%
Cash & Equivalents $25.60M $6.196M
Short-Term Investments
Other Short-Term Assets $170.0K $183.0K
YoY Change -99.02% -98.95%
Inventory $891.0K $631.0K
Prepaid Expenses
Receivables $76.00K $104.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $26.74M $7.114M
YoY Change 0.13% -70.52%
LONG-TERM ASSETS
Property, Plant & Equipment $12.39M $11.95M
YoY Change 167.6% 261.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.000M $2.000M
YoY Change 0.0% 0.0%
Other Assets $532.0K $445.0K
YoY Change -52.75% -50.17%
Total Long-Term Assets $15.25M $14.77M
YoY Change 84.56% 118.74%
TOTAL ASSETS
Total Short-Term Assets $26.74M $7.114M
Total Long-Term Assets $15.25M $14.77M
Total Assets $41.98M $21.88M
YoY Change 20.08% -29.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $987.0K $776.0K
YoY Change 13.84% -13.59%
Accrued Expenses $2.256M $1.986M
YoY Change -21.2% -14.8%
Deferred Revenue
YoY Change
Short-Term Debt $30.00K $34.00K
YoY Change -99.49%
Long-Term Debt Due $50.00K $61.00K
YoY Change -20.63% 15.09%
Total Short-Term Liabilities $3.589M $3.112M
YoY Change -67.86% -11.52%
LONG-TERM LIABILITIES
Long-Term Debt $2.920M $2.926M
YoY Change 5114.29% 3603.8%
Other Long-Term Liabilities $30.00K $100.0K
YoY Change -89.8% -93.77%
Total Long-Term Liabilities $2.950M $3.026M
YoY Change 742.86% 79.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.589M $3.112M
Total Long-Term Liabilities $2.950M $3.026M
Total Liabilities $6.543M $6.138M
YoY Change -43.19% 18.02%
SHAREHOLDERS EQUITY
Retained Earnings -$213.2M -$208.6M
YoY Change 9.16% 9.0%
Common Stock $249.1M $225.0M
YoY Change 13.89% 3.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.44M $15.74M
YoY Change
Total Liabilities & Shareholders Equity $41.98M $21.88M
YoY Change 20.08% -29.15%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$4.547M -$4.759M
YoY Change 17.04% 50.32%
Depreciation, Depletion And Amortization $254.0K $200.0K
YoY Change 27.0% 100.0%
Cash From Operating Activities -$3.250M $8.335M
YoY Change 9.83% -401.99%
INVESTING ACTIVITIES
Capital Expenditures $780.0K $248.0K
YoY Change -159.23% -134.69%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$41.00K
YoY Change -100.0% -34.92%
Cash From Investing Activities -$780.0K -$289.0K
YoY Change -40.86% -62.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.44M -5.205M
YoY Change 228.02% -663.92%
NET CHANGE
Cash From Operating Activities -3.250M 8.335M
Cash From Investing Activities -780.0K -289.0K
Cash From Financing Activities 23.44M -5.205M
Net Change In Cash 19.41M 2.841M
YoY Change 576.78% -208.64%
FREE CASH FLOW
Cash From Operating Activities -$3.250M $8.335M
Capital Expenditures $780.0K $248.0K
Free Cash Flow -$4.030M $8.087M
YoY Change 145.43% -495.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84018082
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83507450
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79481751
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79481751
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
510632
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
aqms Percentage Of Revenue From Products Transferred At Point In Time
PercentageOfRevenueFromProductsTransferredAtPointInTime
1 pure
CY2023Q2 aqms Percentage Of Revenue From Products Transferred At Point In Time
PercentageOfRevenueFromProductsTransferredAtPointInTime
1 pure
CY2022Q2 aqms Percentage Of Revenue From Products Transferred At Point In Time
PercentageOfRevenueFromProductsTransferredAtPointInTime
1 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37515
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1169572
dei Entity Address Address Line1
EntityAddressAddressLine1
5370 Kietzke Lane, Suite 201
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89511
dei City Area Code
CityAreaCode
775
dei Local Phone Number
LocalPhoneNumber
446-4418
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
AQMS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
103184859
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6196000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7082000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12000 usd
CY2023Q2 us-gaap Sales Type Lease Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss Current
SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
0 usd
CY2022Q4 us-gaap Sales Type Lease Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss Current
SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
15527000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
631000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
278000 usd
CY2023Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
47000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
183000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
7114000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
23209000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11951000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7343000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
371000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
461000 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
2000000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
2000000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
445000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
489000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
14767000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
10293000 usd
CY2023Q2 us-gaap Assets
Assets
21881000 usd
CY2022Q4 us-gaap Assets
Assets
33502000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
776000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1075000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1986000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1780000 usd
CY2023Q2 aqms Building Purchase Deposit Current
BuildingPurchaseDepositCurrent
0 usd
CY2022Q4 aqms Building Purchase Deposit Current
BuildingPurchaseDepositCurrent
3250000 usd
CY2023Q2 aqms Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
316000 usd
CY2022Q4 aqms Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
307000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
34000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5899000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3112000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12311000 usd
CY2023Q2 aqms Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
118000 usd
CY2022Q4 aqms Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
275000 usd
CY2023Q2 aqms Building Purchase Deposit Noncurrent
BuildingPurchaseDepositNoncurrent
2908000 usd
CY2022Q4 aqms Building Purchase Deposit Noncurrent
BuildingPurchaseDepositNoncurrent
0 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6138000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12586000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
84000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
79000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
224878000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220114000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-208642000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-199277000 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
577000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
-0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
15743000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20916000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21881000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33502000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1481000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1048000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2546000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2043000 usd
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
525000 usd
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
521000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
970000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1072000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2849000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2390000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5855000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5154000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
4855000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
3959000 usd
us-gaap Costs And Expenses
CostsAndExpenses
9371000 usd
us-gaap Costs And Expenses
CostsAndExpenses
8269000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4855000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3955000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9371000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8265000 usd
CY2023Q2 aqms Gain Loss On Sale Of Property Plant And Equipment Excluding Amount In Cost Of Good Sold
GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold
3000 usd
CY2022Q2 aqms Gain Loss On Sale Of Property Plant And Equipment Excluding Amount In Cost Of Good Sold
GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold
739000 usd
aqms Gain Loss On Sale Of Property Plant And Equipment Excluding Amount In Cost Of Good Sold
GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold
23000 usd
aqms Gain Loss On Sale Of Property Plant And Equipment Excluding Amount In Cost Of Good Sold
GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold
590000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
255000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
12000 usd
us-gaap Interest Expense
InterestExpense
431000 usd
us-gaap Interest Expense
InterestExpense
12000 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
348000 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
62000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
414000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
113000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
96000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
789000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
691000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4759000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3166000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9365000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7574000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4759000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3166000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9365000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7576000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84184884
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75215009
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82743345
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73584761
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
19076000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
599000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4759000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
15743000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20916000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1285000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
500000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
12000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
577000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
122000 usd
aqms Stock Issued During Period Value Issued For Class Action Settlement
StockIssuedDuringPeriodValueIssuedForClassActionSettlement
501000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9365000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
15743000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27618000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
534000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3166000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
25684000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
27533000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1138000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7576000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
25684000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9365000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7576000 usd
aqms Depreciation And Right Of Use Asset Amortization
DepreciationAndRightOfUseAssetAmortization
455000 usd
aqms Depreciation And Right Of Use Asset Amortization
DepreciationAndRightOfUseAssetAmortization
548000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
90000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
90000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
64000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
aqms Fair Value Of Common Stock Issued For Consulting Services
FairValueOfCommonStockIssuedForConsultingServices
12000 usd
aqms Fair Value Of Common Stock Issued For Consulting Services
FairValueOfCommonStockIssuedForConsultingServices
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1286000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1139000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
112000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
23000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
590000 usd
aqms Proceeds From Sales Type Lease Payments Financing Activities
ProceedsFromSalesTypeLeasePaymentsFinancingActivities
12278000 usd
aqms Proceeds From Sales Type Lease Payments Financing Activities
ProceedsFromSalesTypeLeasePaymentsFinancingActivities
410000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
90000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-273000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
353000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-95000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-80000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-45000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
49000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1024000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
147000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
357000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5472000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5939000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5503000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
973000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
67000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1145000 usd
aqms Payments To Acquire Equipment Deposits And Other Assets
PaymentsToAcquireEquipmentDepositsAndOtherAssets
75000 usd
aqms Payments To Acquire Equipment Deposits And Other Assets
PaymentsToAcquireEquipmentDepositsAndOtherAssets
33000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5511000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-361000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
14000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2932000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
577000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2784000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4588000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-847000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4588000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-886000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1712000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7082000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8137000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6196000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6425000 usd
us-gaap Interest Paid Net
InterestPaidNet
309000 usd
us-gaap Interest Paid Net
InterestPaidNet
5000 usd
aqms Change In Property And Equipment Resulting From Change In Accounts Payable
ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable
349000 usd
aqms Change In Property And Equipment Resulting From Change In Accounts Payable
ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable
-218000 usd
aqms Change In Property And Equipment Resulting From Change In Accrued Expenses
ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses
210000 usd
aqms Change In Property And Equipment Resulting From Change In Accrued Expenses
ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses
0 usd
aqms Change In Equity Resulting From Change In Accrued Expenses
ChangeInEquityResultingFromChangeInAccruedExpenses
608000 usd
aqms Change In Equity Resulting From Change In Accrued Expenses
ChangeInEquityResultingFromChangeInAccruedExpenses
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><span style="text-decoration: underline; "><em style="font: inherit;">1.</em> Organization</span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt; text-indent: 0pt; text-align: justify;">Aqua Metals (NASDAQ: <span style="text-decoration: underline; ">AQMS</span>) is engaged in the business of applying its commercialized clean, water-based recycling technology principles to develop the clean and cost-efficient recycling solutions for both lead and lithium-ion (“Li”) batteries. Our recycling process is a patented hydro and electrometallurgical technology that is a novel, proprietary and patented process we developed and named AquaRefining. AquaRefining is a low-emissions, closed-loop recycling technology that replaces polluting furnaces and hazardous chemicals with electricity-powered electroplating to recover valuable metals and materials from spent batteries with higher purity, lower emissions, and with minimal waste. The modular “Aqualyzers” cleanly generate ultra-pure metal <em style="font: inherit;">one</em> atom at a time, closing the sustainability loop for the rapidly growing energy storage economy.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt; text-indent: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt; text-indent: 0pt; text-align: justify;">We are in the process of demonstrating that Li AquaRefining, which is fundamentally non-polluting, can create the highest quality and highest yields of recovered minerals from lithium-ion batteries with lower waste streams and lower costs than existing alternatives. We have already demonstrated at our pilot facility our ability to recover key valuable minerals in lithium-ion batteries, such as lithium hydroxide, copper, nickel, cobalt, and other compounds in early <em style="font: inherit;">2023.</em> Our goal is to process commercial quantities of nickel, cobalt, and copper in a pure metal form that can be sold to the general metals and superalloy markets and can be made into battery precursor compound materials with known processes already used in the mining industry. We have installed, commissioned, and began to operate the <em style="font: inherit;">first</em> Li AquaRefining pilot plant, scaling towards a commercial demonstration operation through <em style="font: inherit;">2023.</em></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt; text-indent: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt; text-indent: 0pt; text-align: justify;">Our focus for the lead market is providing equipment and licensing of our lead acid battery recycling technologies in an enabler model which allows us to work with anyone in the industry globally and address the entire marketplace. Our focus for the lithium market includes operating and licensing our <em style="font: inherit;">first</em>-of-a-kind lithium battery recycling facility, utilizing electricity to recycle instead of intensive chemical processes, fossil fuels, or high-temperature furnaces.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 26pt; text-align: justify; text-indent: 0pt;"><span style="text-decoration: underline; ">Use of estimates</span></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 26pt; text-align: justify; text-indent: 0pt;">The preparation of the condensed consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of expenses during the period. Significant items subject to such estimates and assumptions include the carrying amount and valuation of long-lived assets, valuation allowances for deferred tax assets, the determination of stock-based compensation expense and the determination of the fair value of stock warrants issued. Actual results could differ from those estimates.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 26pt; text-align: justify; text-indent: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 26pt; text-align: justify; text-indent: 0pt;"></p>
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6605262
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5154251
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6481403
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5307642
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 26pt; text-align: justify; text-indent: 0pt;"><span style="text-decoration: underline; ">Concentration of credit risk</span></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 26pt; text-align: justify; text-indent: 0pt;">The Company did <span style="-sec-ix-hidden:c101298976"><span style="-sec-ix-hidden:c101298977"><span style="-sec-ix-hidden:c101298978"><span style="-sec-ix-hidden:c101298979">not</span></span></span></span> generate significant revenue during the <em style="font: inherit;">three</em> and <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022</em>, respectively, except for nominal revenue generated during the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2022</em> from the sale of inventory. The Company did <span style="-sec-ix-hidden:c101298985"><span style="-sec-ix-hidden:c101298987">not</span></span> have a trade receivable balance as of <em style="font: inherit;"> June 30, 2023</em> and <em style="font: inherit;"> December 31, 2022</em>. The accounts receivable balance on the Company's condensed consolidated balance sheets as of <em style="font: inherit;"> June 30, 2023</em> consisted of proceeds from a non-recurring engineering (NRE) agreement with <em style="font: inherit;">6K</em> Energy and the sale of equipment. The accounts receivable balance on the Company's consolidated balance sheets as of <em style="font: inherit;"> December 31, 2022</em> consisted of proceeds from the sale of equipment.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt; text-align: justify;"></p>
aqms Percentage Of Revenue From Products Transferred At Point In Time
PercentageOfRevenueFromProductsTransferredAtPointInTime
1 pure
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLoss
17000000.0 usd
CY2023Q1 aqms Salestype Lease Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss Implied Interest Rate
SalestypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossImpliedInterestRate
0.005 pure
aqms Proceeds From Sales Type Lease Payments Financing Activities
ProceedsFromSalesTypeLeasePaymentsFinancingActivities
12300000 usd
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
24000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
603000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
250000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
631000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
278000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13468000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8837000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1517000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1494000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11951000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7343000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
200000 usd
us-gaap Depreciation
Depreciation
300000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
100000 usd
us-gaap Depreciation
Depreciation
200000 usd
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1134000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
418000 usd
CY2023Q2 aqms Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
560000 usd
CY2022Q4 aqms Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
770000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
171000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
41000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
121000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
51000 usd
CY2023Q2 aqms Accrued Class Action Settlement Liabilities Current
AccruedClassActionSettlementLiabilitiesCurrent
0 usd
CY2022Q4 aqms Accrued Class Action Settlement Liabilities Current
AccruedClassActionSettlementLiabilitiesCurrent
500000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1986000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1780000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
580000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
66000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
150000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
133000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
214000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
65000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
141000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
131000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
207000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000 usd
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
17000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
29000 usd
CY2023Q2 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
2000 usd
CY2022Q2 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
2000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
2000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
5000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0616 pure
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M18D
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0748 pure
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
269000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
65000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
102000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
18000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
0 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16000 usd
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
355000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
79000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
34000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5899000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
2908000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
510632
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
577000 usd
aqms Stock Issued During Period Shares Issued For Class Action Settlement
StockIssuedDuringPeriodSharesIssuedForClassActionSettlement
469366
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
192707
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
599000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
534000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1286000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1139000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0

Files In Submission

Name View Source Status
0001437749-23-022774-index-headers.html Edgar Link pending
0001437749-23-022774-index.html Edgar Link pending
0001437749-23-022774.txt Edgar Link pending
0001437749-23-022774-xbrl.zip Edgar Link pending
aqms-20230630.xsd Edgar Link pending
aqms-20230630_cal.xml Edgar Link unprocessable
aqms-20230630_lab.xml Edgar Link unprocessable
aqms-20230630_def.xml Edgar Link unprocessable
aqms-20230630_pre.xml Edgar Link unprocessable
aqms20230630_10q.htm Edgar Link pending
ex_524605.htm Edgar Link pending
ex_524606.htm Edgar Link pending
ex_524607.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
aqms20230630_10q_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable